…
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Pfizer CDR (CAD Hedged) is a Toronto-listed Canadian depositary receipt giving investors exposure to Pfizer Inc., a global pharmaceutical company that develops, manufactures and sells medicines and vaccines. Long-term growth drivers include its R&D pipeline, recurring revenues from established products and ageing-population-driven healthcare demand, while the CAD hedge may reduce currency volatility for Canadian holders and provide local-market liquidity.
Material risks include clinical or regulatory setbacks, product patent expirations and pricing or reimbursement pressure in pharmaceuticals, along with hedging costs and counterparty risk tied to the CAD‑hedged structure.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
|
Stock Name
|
Change
(CAD) |
Price
(CAD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| PFE Pfizer CDR (CAD Hedged) |
0.32 2.41% |
13.62 | 19.51 | 9.03 | 2.42 | 1.74 | 3.31 | 12.33 |
| AVGO Broadcom CDR (CAD Hedged) |
-0.24 1.95% |
12.35 | 12.44 | 5.73 | 4.54 | 3.78 | 28.65 | 52.40 |
| WMT Walmart CDR (CAD Hedged) |
2.30 4.43% |
54.19 | 45.06 | 41.67 | 1.38 | 9.84 | 1.51 | 23.16 |
| LLY Eli Lilly CDR (CAD Hedged) |
0.38 0.76% |
50.60 | 37.91 | 25.77 | 12.03 | 29.35 | 12.92 | 26.57 |
| JPM JPMorgan CDR (CAD Hedged) |
1.61 3.76% |
44.45 | 14.46 | 14.03 | 4.49 | 2.36 | 6.97 | - |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.